{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-23T17:10:43.125432",
    "items": [
        {
            "title": "What's Going On With Super League Stock?",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/01/50109901/whats-going-on-with-super-league-stock",
            "description": "Super League Enterprise, Inc. (NASDAQ:SLE) shares are down on Friday after the advertising company announced an exclusive partnership with Solsten to ...",
            "pubDate": "2026-01-23T20:06:53",
            "image_url": "https://cdn.benzinga.com/files/images/story/2026/01/23/Advertising---Testimonial-Photo-Of-Marke.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "What Analysts Are Saying About Banc of California Stock",
            "link": "https://www.benzinga.com/insights/analyst-ratings/26/01/50109698/what-analysts-are-saying-about-banc-of-california-stock",
            "description": "Latest Ratings for BANC Date Firm Action From To Jan 2022 Raymond James Maintains Outperform Oct 2021 Raymond James Maintains Outperform Jul 2021 Raym...",
            "pubDate": "2026-01-23T20:01:13",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "A Glimpse Into The Expert Outlook On Jacobs Solutions Through 9 Analysts",
            "link": "https://www.benzinga.com/insights/analyst-ratings/26/01/50109688/a-glimpse-into-the-expert-outlook-on-jacobs-solutions-through-9-analysts",
            "description": "Latest Ratings for J Date Firm Action From To Feb 2022 Credit Suisse Maintains Outperform Dec 2021 Barclays Maintains Overweight Nov 2021 Citigroup Ma...",
            "pubDate": "2026-01-23T20:01:04",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "What Analysts Are Saying About Neurocrine Biosciences Stock",
            "link": "https://www.benzinga.com/insights/analyst-ratings/26/01/50109678/what-analysts-are-saying-about-neurocrine-biosciences-stock",
            "description": "Latest Ratings for NBIX Date Firm Action From To Mar 2022 Piper Sandler Downgrades Overweight Neutral Feb 2022 Goldman Sachs Upgrades Neutral Buy Feb ...",
            "pubDate": "2026-01-23T20:00:56",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Oklo's Options Frenzy: What You Need to Know",
            "link": "https://www.benzinga.com/insights/options/26/01/50109675/oklos-options-frenzy-what-you-need-to-know",
            "description": "read more",
            "pubDate": "2026-01-23T20:00:53",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        }
    ]
}